SCHEMBL8285265

SCHEMBL8285265

CCOC(=O)CSc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.46
HPGD P15428 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 2/20 0.46
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HSD17B10 Q99714 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PKM P14618 1/20 0.40
USP2 O75604 1/20 0.40
CSF1R P07333 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286498 0.88 GAA (0.47) ALDH1A1HPGDSMN1; SMN2TSHRLMNA
SCHEMBL8287236 0.87 MAT2A (0.40) ALDH1A1MAPTTSHRLMNAMEN1
SCHEMBL8286471 0.85 PDE7A (0.38) ALDH1A1HPGDSMN1; SMN2MAPTLMNA
SCHEMBL8287235 0.85 NPC1 (0.49) ALDH1A1SMN1; SMN2MAPTTSHRLMNA
SCHEMBL8287248 0.83 MEN1 (0.43) ALDH1A1SMN1; SMN2MAPTLMNAMEN1
SCHEMBL8287565 0.83 HTT (0.41) ALDH1A1HPGDSMN1; SMN2MAPTTSHR
SCHEMBL8287930 0.82 CSF1R (0.47) ALDH1A1HPGDSMN1; SMN2MAPTLMNA
SCHEMBL8287247 0.82 ALDH1A1 (0.46) ALDH1A1HPGDSMN1; SMN2TSHRLMNA
SCHEMBL8285328 0.81 GSK3B (0.38) ALDH1A1HPGDSMN1; SMN2LMNAMEN1
SCHEMBL8287515 0.81 BCL6 (0.40) ALDH1A1HPGDSMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed